StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research note published on Friday. The firm issued a sell rating on the medical technology company’s stock. Several other equities analysts have also weighed in on the company. Maxim Group lowered BIOLASE from a strong-buy rating to a hold rating in a […]

Leave a Reply

Your email address will not be published.

Previous post Model N (NYSE:MODN) Earns Hold Rating from Analysts at StockNews.com
Next post Air Products and Chemicals (NYSE:APD) Upgraded at StockNews.com